A cost-effectiveness analysis of Molnupiravir and Paxlovid in three African countries https://www.medrxiv.org/content/10.1101/2023.07.05.23292205
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.